For example, the reactivation of p53 by Nutlin-3 and the inhibition of AKT/mTOR by tanshinone IIA exhibit a synergetic antileukemia effect with Imatinib in Philadelphia-positive ALL [83]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.